The Role of Perfluorocarbons in Mitigating Traumatic Brain Injury

Abstract

Neurological injury [brain and cord] is always accompanied by tissue deprivation of glucose and oxygen (ischemia/hypoxia). Most of the damage seems to be mediated by mechanisms that follow the initial injury (secondary mechanisms). Perfluorocarbons (PFCs) are one of the methods by which oxygen delivery to tissue can be achieved after injury. The rationale for PFCs in traumatic brain injury has been well established in animal studies and early phase 2 clinical trials. Currently three perfluorocarbons are available in the United States for testing, but none of these have been FDA approved and only for one of them Oxycyte has the process of application for FDA approval even been commenced. For the third generation perfluorocarbon (Oxycyte) a possible side effect that has emerged in humans is transient mild thrombocytopenia. It is uncertain at this time whether this side effect will prove to be a limiting factor, which may jeopardize the use of these compounds as a class, or just affect Oxycyte in particular following traumatic brain and spinal cord injury. Any agent that might exacerbate thrombocytopenia in intracranial hemorrhage into traumatic contusions is dangerous for obvious reasons. The purpose of this grant therefore is to cross compare the safety and efficacy of three perfluorocarbons namely Oxycyte, Perftec and Oxygent. We assessed these 3 PFC agents in two head injury models (1) new PENETRATING brain injury animal model (human gunshot wound to head) and (2) closed severe rat TBI Fluid Percussion Injury (human car crash) with a secondary Hypoxic insult. We measured how the PFCs alter the ability of the injured brain (1) to use glucose, oxygen and (2) lower cell death caused by injury, (3) effect on blood clotting. First, we did not find any evidence of impairment of blood clotting in rats with TBI after treatment with PFCs unlike in humans.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
May 01, 2014
Accession Number
ADA606019

Entities

People

  • M. R. Bullock

Organizations

  • University of Miami

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Blood
  • Blood Coagulation
  • Brain Injuries
  • Cell Physiological Processes
  • Cerebrovascular Disorders
  • Clinical Trials
  • Data Analysis
  • Medical Personnel
  • Metabolism
  • Neurodegeneration
  • Side Effects
  • Spinal Injuries
  • Stress (Physiology)
  • Tissues
  • United States
  • Wounds And Injuries

Fields of Study

  • Medicine

Readers

  • Cardiovascular Physiology
  • Neurotrauma and Rehabilitation Medicine.